Molecular diagnostics company
AI-generated insights about Exact Sciences Corporation from various financial sources
Leading the shift from invasive procedures to stool-based testing with Cologuard; benefits from the 'offensive' health stack theme.
Mentioned in the context of being acquired by Abbott (ABT), a past event which caused the stock to jump 18%. This was a positive outcome for former shareholders.
Leading the shift from invasive procedures to stool-based testing with Cologuard; benefits from the 'offensive' health stack theme.
Mentioned in the context of being acquired by Abbott (ABT), a past event which caused the stock to jump 18%. This was a positive outcome for former shareholders.